234 related articles for article (PubMed ID: 17225936)
1. Hyperdiploidy defines a distinct cytogenetic entity of meningiomas.
Ketter R; Kim YJ; Storck S; Rahnenführer J; Romeike BF; Steudel WI; Zang KD; Henn W
J Neurooncol; 2007 Jun; 83(2):213-21. PubMed ID: 17225936
[TBL] [Abstract][Full Text] [Related]
2. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
Müller P; Henn W; Niedermayer I; Ketter R; Feiden W; Steudel WI; Zang KD; Steilen-Gimbel H
Clin Cancer Res; 1999 Nov; 5(11):3569-77. PubMed ID: 10589773
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes).
Heerema NA; Sather HN; Sensel MG; Zhang T; Hutchinson RJ; Nachman JB; Lange BJ; Steinherz PG; Bostrom BC; Reaman GH; Gaynon PS; Uckun FM
J Clin Oncol; 2000 May; 18(9):1876-87. PubMed ID: 10784628
[TBL] [Abstract][Full Text] [Related]
4. Monosomy 7p in meningiomas: a rare constituent of tumor progression.
Henn W; Niedermayer I; Ketter R; Reichardt S; Freiler A; Zang KD
Cancer Genet Cytogenet; 2003 Jul; 144(1):65-8. PubMed ID: 12810258
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases.
Ketter R; Henn W; Niedermayer I; Steilen-Gimbel H; König J; Zang KD; Steudel WI
J Neurosurg; 2001 Oct; 95(4):601-7. PubMed ID: 11596954
[TBL] [Abstract][Full Text] [Related]
6. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.
Ketter R; Rahnenführer J; Henn W; Kim YJ; Feiden W; Steudel WI; Zang KD; Urbschat S
Neurosurgery; 2008 Jan; 62(1):61-9; discussion 69-70. PubMed ID: 18300892
[TBL] [Abstract][Full Text] [Related]
7. Meningiomas: karyotypes and histological patterns.
Lopez-Gines C; Piquer J; Cerda-Nicolas M; Barcia-Salorio J; Barcia-Marino C
Clin Neuropathol; 1989; 8(3):130-3. PubMed ID: 2743649
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
9. Telomeric association of chromosomes in human meningiomas.
Vagner-Capodano AM; Grisoli F; Gambarelli D; Figarella D; Pellissier JF
Ann Genet; 1992; 35(2):69-74. PubMed ID: 1524412
[TBL] [Abstract][Full Text] [Related]
10. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.
Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W
Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658
[TBL] [Abstract][Full Text] [Related]
11. Correlation between cytogenetic and clinical findings in 215 human meningiomas.
Steudel WI; Feld R; Henn W; Zang KD
Acta Neurochir Suppl; 1996; 65():73-6. PubMed ID: 8738501
[TBL] [Abstract][Full Text] [Related]
12. Genetic changes with prognostic value in histologically benign meningiomas.
Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
[TBL] [Abstract][Full Text] [Related]
14. Clonal cytogenetic progression within intratumorally heterogeneous meningiomas predicts tumor recurrence.
Urbschat S; Rahnenführer J; Henn W; Feiden W; Wemmert S; Linsler S; Zang KD; Oertel J; Ketter R
Int J Oncol; 2011 Dec; 39(6):1601-8. PubMed ID: 21922133
[TBL] [Abstract][Full Text] [Related]
15. Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas.
Henn W; Cremerius U; Heide G; Lippitz B; Schröder JM; Gilsbach JM; Büll U; Zang KD
Cancer Genet Cytogenet; 1995 Feb; 79(2):144-8. PubMed ID: 7889508
[TBL] [Abstract][Full Text] [Related]
16. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
[TBL] [Abstract][Full Text] [Related]
17. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal instability in meningiomas.
van Tilborg AA; Al Allak B; Velthuizen SC; de Vries A; Kros JM; Avezaat CJ; de Klein A; Beverloo HB; Zwarthoff EC
J Neuropathol Exp Neurol; 2005 Apr; 64(4):312-22. PubMed ID: 15835267
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal involvement secondary to -22 in human meningiomas.
Rey JA; Bello MJ; de Campos JM; Kusak E; Moreno S
Cancer Genet Cytogenet; 1988 Jul; 33(2):275-90. PubMed ID: 3383169
[TBL] [Abstract][Full Text] [Related]
20. Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas.
Ketter R; Urbschat S; Henn W; Feiden W; Beerenwinkel N; Lengauer T; Steudel WI; Zang KD; Rahnenführer J
Int J Cancer; 2007 Oct; 121(7):1473-80. PubMed ID: 17557299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
